Suppr超能文献

一名新冠病毒检测呈阳性男性的原发性异烟肼单耐药肺结核:当前大流行中全球首例此类病例。

Primary Isoniazid Mono-Resistant Pulmonary Tuberculosis in a COVID-19-Positive Male: World's First Case of Its Kind in the Present Pandemic.

作者信息

Yadav Sankalp

机构信息

Medicine, Shri Madan Lal Khurana Chest Clinic, New Delhi, IND.

出版信息

Cureus. 2022 Jul 23;14(7):e27163. doi: 10.7759/cureus.27163. eCollection 2022 Jul.

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has resulted in numerous rare presentations of common diseases. The diseases that were prevalent for a long time like tuberculosis (TB) have been reported in cases of COVID-19. The reports of drug-sensitive, multidrug-resistant, and pre-extensively drug-resistant TB with COVID-19 are available in the medical literature. The situation in high TB burden countries where TB is a great contributor to morbidity and mortality is grisly. Herein, a case of primary isoniazid mono-resistant pulmonary tuberculosis in a COVID-19-positive Indian male is reported. As far as the literature is concerned, no case similar to our index case is ever reported.

摘要

2019年冠状病毒病(COVID-19)大流行导致许多常见疾病出现了罕见表现。长期流行的疾病,如结核病(TB),已在COVID-19病例中被报道。医学文献中有关于COVID-19合并药物敏感型、耐多药型和广泛耐药前型结核病的报告。在结核病负担较高的国家,结核病是发病率和死亡率的重要因素,情况严峻。在此,报告了一例COVID-19阳性的印度男性原发性异烟肼单耐药型肺结核病例。就文献而言,从未报道过与我们的索引病例类似的病例。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验